PomDoctor Ltd. Unsponsored ADR(POM)
$1.660.00 (0.00%)
POM
PomDoctor Ltd. Unsponsored ADR financials statements
$1.66
At close:0.00 (0.00%)
Want to see POM full AI Analyst Report?
PomDoctor Ltd. Unsponsored ADR (POM) Ratios
43 Followers
PomDoctor Ltd. Unsponsored ADR Ratios
POM's free cash flow for Q2 2026 was ¥1.45M. For the 2026 fiscal year, POM's free cash flow was decreased by ¥-19.45K and operating cash flow was ¥1.47M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.48 | 0.21 | 0.35 | 0.33 | 0.17 |
| Quick Ratio | 0.44 | 0.16 | 0.27 | 0.28 | 0.09 |
| Cash Ratio | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 |
| Solvency Ratio | -0.36 | -0.07 | -0.07 | -0.06 | -0.09 |
| Operating Cash Flow Ratio | -0.68 | -0.09 | -0.27 | -0.15 | -0.14 |
| Short-Term Operating Cash Flow Coverage | -1.80 | -0.22 | -0.83 | -0.75 | -0.67 |
| Net Current Asset Value | ¥ -483.89M | ¥ -2.10B | ¥ -1.97B | ¥ -1.90B | ¥ -1.78B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 4.23 | 9.54 | 6.23 | 7.43 | 17.67 |
| Debt-to-Equity Ratio | -1.00 | -0.19 | -0.19 | -0.18 | -0.18 |
| Debt-to-Capital Ratio | 469.67 | -0.24 | -0.24 | -0.22 | -0.23 |
| Long-Term Debt-to-Capital Ratio | -4.37 | -0.19 | -0.20 | -0.19 | -0.20 |
| Financial Leverage Ratio | -0.24 | -0.02 | -0.03 | -0.02 | -0.01 |
| Debt Service Coverage Ratio | -1.23 | -0.28 | -0.33 | -0.08 | -1.48 |
| Interest Coverage Ratio | -9.03 | -1.99 | -1.61 | -0.22 | -4.89 |
| Debt to Market Cap | 1.13 | 0.13 | 0.12 | 0.11 | 0.11 |
| Interest Debt Per Share | 144.98 | 69.00 | 3.61 | 3.19 | 3.02 |
| Net Debt to EBITDA | -3.78 | -17.86 | -17.69 | -94.19 | -5.79 |
| Profitability Margins | |||||
| Gross Profit Margin | 13.07% | 13.92% | 12.70% | 22.37% | 24.38% |
| EBIT Margin | -29.52% | -7.12% | -7.58% | -1.55% | -37.09% |
| EBITDA Margin | -29.48% | -7.08% | -7.54% | -1.55% | -27.20% |
| Operating Profit Margin | -29.10% | -7.53% | -7.30% | -1.47% | -36.99% |
| Pretax Profit Margin | -32.74% | -10.91% | -12.12% | -8.09% | -44.66% |
| Net Profit Margin | -53.16% | -41.85% | -47.69% | -51.18% | -87.47% |
| Continuous Operations Profit Margin | -32.74% | -10.91% | -12.12% | -8.09% | -44.66% |
| Net Income Per EBT | 162.36% | 383.67% | 393.49% | 632.87% | 195.88% |
| EBT Per EBIT | 112.51% | 144.88% | 166.07% | 551.77% | 120.73% |
| Return on Assets (ROA) | -197.64% | -310.12% | -219.27% | -258.16% | -975.61% |
| Return on Equity (ROE) | 46.83% | 6.33% | 6.86% | 6.36% | 10.19% |
| Return on Capital Employed (ROCE) | 105.21% | 19.40% | 21.05% | 3.78% | 88.44% |
| Return on Invested Capital (ROIC) | 441.53% | 44.03% | 45.39% | 5.61% | 123.95% |
| Return on Tangible Assets | -197.64% | -310.12% | -219.27% | -258.16% | -975.61% |
| Earnings Yield | -53.26% | -4.11% | -4.29% | -3.81% | -6.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 16.11 | 22.88 | 9.41 | 9.00 | 291.23 |
| Payables Turnover | 7.76 | 11.63 | 6.38 | 4.39 | 5.36 |
| Inventory Turnover | 41.98 | 32.17 | 20.96 | 23.23 | 20.06 |
| Fixed Asset Turnover | 320.81 | 742.49 | 511.61 | 0.00 | 0.00 |
| Asset Turnover | 3.72 | 7.41 | 4.60 | 5.04 | 11.15 |
| Working Capital Turnover Ratio | -3.14 | -2.69 | -2.92 | -2.63 | 0.00 |
| Cash Conversion Cycle | -15.71 | -4.07 | -0.99 | -26.84 | -48.69 |
| Days of Sales Outstanding | 22.65 | 15.95 | 38.78 | 40.57 | 1.25 |
| Days of Inventory Outstanding | 8.69 | 11.35 | 17.41 | 15.71 | 18.19 |
| Days of Payables Outstanding | 47.06 | 31.38 | 57.18 | 83.12 | 68.14 |
| Operating Cycle | 31.35 | 27.30 | 56.19 | 56.28 | 19.45 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -46.02 | -2.45 | -0.39 | -0.19 | -0.13 |
| Free Cash Flow Per Share | -46.33 | -2.46 | -0.39 | -0.19 | -0.13 |
| Dividend Paid and CapEx Coverage Ratio | -147.34 | -427.05 | -409.29 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -147.34 | -427.05 | -409.29 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.33 | -0.04 | -0.11 | -0.06 | -0.05 |
| Operating Cash Flow to Sales Ratio | -0.37 | -0.05 | -0.15 | -0.09 | -0.07 |
| Free Cash Flow Yield | -37.45% | -0.46% | -1.36% | -0.67% | -0.52% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.88 | -24.31 | -23.30 | -26.23 | -16.09 |
| Price-to-Sales (P/S) Ratio | 1.00 | 10.17 | 11.11 | 13.43 | 14.08 |
| Price-to-Book (P/B) Ratio | -0.88 | -1.54 | -1.60 | -1.67 | -1.64 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.67 | -215.48 | -73.80 | -149.53 | -193.35 |
| Price-to-Operating Cash Flow Ratio | -2.69 | -215.98 | -73.98 | -149.53 | -193.35 |
| Price-to-Earnings Growth (PEG) Ratio | 0.56 | 14.95 | -1.45 | 0.79 | 0.00 |
| Enterprise Value Multiple | -7.16 | -161.43 | -165.06 | -958.61 | -57.55 |
| Enterprise Value | 844.51M | 3.92B | 3.79B | 3.65B | 3.37B |
| EV to EBITDA | -7.16 | -161.43 | -165.06 | -958.61 | -57.55 |
| EV to Sales | 2.11 | 11.44 | 12.45 | 14.89 | 15.65 |
| EV to Free Cash Flow | -5.65 | -242.28 | -82.65 | -165.82 | -214.98 |
| EV to Operating Cash Flow | -5.69 | -242.85 | -82.85 | -165.82 | -214.98 |
| Tangible Book Value Per Share | -149.16 | -318.34 | -16.56 | -16.02 | -15.01 |
| Shareholders’ Equity Per Share | -140.69 | -343.97 | -17.90 | -16.67 | -15.61 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 123.94 | 52.06 | 2.57 | 2.07 | 1.82 |
| Net Income Per Share | -65.88 | -21.79 | -1.23 | -1.06 | -1.59 |
| Tax Burden | 1.62 | 3.84 | 3.93 | 6.33 | 1.96 |
| Interest Burden | 1.11 | 1.53 | 1.60 | 5.21 | 1.20 |
| Research & Development to Revenue | 0.03 | 0.01 | 0.01 | 0.01 | 0.02 |
| SG&A to Revenue | 0.39 | 0.20 | 0.04 | 0.03 | 0.09 |
| Stock-Based Compensation to Revenue | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.13 | 0.43 | 1.24 | 1.11 | 0.16 |
Currency in CNY
